Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Aviva PLC

Aviva PLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 34.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,153 shares of the biotechnology company's stock after selling 36,226 shares during the quarter. Aviva PLC owned 0.09% of Axon Enterprise worth $41,693,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. Asset Dedication LLC increased its position in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after acquiring an additional 18 shares during the last quarter. Bleakley Financial Group LLC boosted its position in shares of Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC increased its holdings in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after purchasing an additional 21 shares during the last quarter. Insigneo Advisory Services LLC raised its position in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after purchasing an additional 22 shares during the period. Finally, Burns Matteson Capital Management LLC lifted its stake in Axon Enterprise by 3.4% during the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company's stock worth $450,000 after purchasing an additional 25 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Activity at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Down 0.1 %

Shares of AXON traded down $0.47 during mid-day trading on Friday, reaching $550.78. The company's stock had a trading volume of 126,488 shares, compared to its average volume of 809,685. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The stock has a market cap of $42.20 billion, a PE ratio of 142.32, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. The company's 50 day moving average is $568.97 and its 200 day moving average is $559.34.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Barclays reissued a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.